153 related articles for article (PubMed ID: 27127136)
1. Elimination of Cigarette Smoke-derived Acetaldehyde in Saliva by Slow-release L-Cysteine Lozenge Is a Potential New Method to Assist Smoking Cessation. A Randomised, Double-blind, Placebo-controlled Intervention.
Syrjänen K; Salminen J; Aresvuo U; Hendolin P; Paloheimo L; Eklund C; Salaspuro M; Suovaniemi O
Anticancer Res; 2016 May; 36(5):2297-306. PubMed ID: 27127136
[TBL] [Abstract][Full Text] [Related]
2. Slow-release L-Cysteine (Acetium®) Lozenge Is an Effective New Method in Smoking Cessation. A Randomized, Double-blind, Placebo-controlled Intervention.
Syrjänen K; Eronen K; Hendolin P; Paloheimo L; Eklund C; Bäckström A; Suovaniemi O
Anticancer Res; 2017 Jul; 37(7):3639-3648. PubMed ID: 28668855
[TBL] [Abstract][Full Text] [Related]
3. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM
JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652
[TBL] [Abstract][Full Text] [Related]
5. Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study.
Batra A; Klingler K; Landfeldt B; Friederich HM; Westin A; Danielsson T
Clin Pharmacol Ther; 2005 Dec; 78(6):689-96. PubMed ID: 16338284
[TBL] [Abstract][Full Text] [Related]
6. [Health Effects Accompanying the Transition from Cigarettes to Heat-not-burn Tobacco: Nicotine Dependence, Nicotine Withdrawal Symptoms, and Changes in Smoking Behaviors].
Kawamura K; Yamada K; Morioka I
Nihon Eiseigaku Zasshi; 2018; 73(3):379-387. PubMed ID: 30270306
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
[TBL] [Abstract][Full Text] [Related]
8. The combined effect of very low nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomized controlled trial.
Walker N; Howe C; Bullen C; Grigg M; Glover M; McRobbie H; Laugesen M; Parag V; Whittaker R
Addiction; 2012 Oct; 107(10):1857-67. PubMed ID: 22594651
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a nicotine lozenge for smoking cessation.
Shiffman S; Dresler CM; Hajek P; Gilburt SJ; Targett DA; Strahs KR
Arch Intern Med; 2002 Jun; 162(11):1267-76. PubMed ID: 12038945
[TBL] [Abstract][Full Text] [Related]
10. Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up.
Benowitz NL; Nardone N; Dains KM; Hall SM; Stewart S; Dempsey D; Jacob P
Addiction; 2015 Oct; 110(10):1667-75. PubMed ID: 26198394
[TBL] [Abstract][Full Text] [Related]
11. Effects of a 2.5-mg silver acetate lozenge on initial and long-term smoking cessation.
Hymowitz N; Eckholdt H
Prev Med; 1996; 25(5):537-46. PubMed ID: 8888321
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
[TBL] [Abstract][Full Text] [Related]
13. Use of more nicotine lozenges leads to better success in quitting smoking.
Shiffman S
Addiction; 2007 May; 102(5):809-14. PubMed ID: 17493108
[TBL] [Abstract][Full Text] [Related]
14. Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial.
Hatsukami DK; Luo X; Jensen JA; al'Absi M; Allen SS; Carmella SG; Chen M; Cinciripini PM; Denlinger-Apte R; Drobes DJ; Koopmeiners JS; Lane T; Le CT; Leischow S; Luo K; McClernon FJ; Murphy SE; Paiano V; Robinson JD; Severson H; Sipe C; Strasser AA; Strayer LG; Tang MK; Vandrey R; Hecht SS; Benowitz NL; Donny EC
JAMA; 2018 Sep; 320(9):880-891. PubMed ID: 30193275
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers.
Weinberger AH; Reutenauer EL; Jatlow PI; O'Malley SS; Potenza MN; George TP
Drug Alcohol Depend; 2010 Mar; 107(2-3):188-95. PubMed ID: 19939587
[TBL] [Abstract][Full Text] [Related]
16. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
Tonstad S; Tønnesen P; Hajek P; Williams KE; Billing CB; Reeves KR;
JAMA; 2006 Jul; 296(1):64-71. PubMed ID: 16820548
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy of nicotine replacement therapy for smoking cessation in adolescents: a randomized controlled trial.
Scherphof CS; van den Eijnden RJ; Engels RC; Vollebergh WA
Drug Alcohol Depend; 2014 Jul; 140():217-20. PubMed ID: 24811201
[TBL] [Abstract][Full Text] [Related]
18. An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women.
Gray KM; McClure EA; Baker NL; Hartwell KJ; Carpenter MJ; Saladin ME
Addiction; 2015 Jun; 110(6):1027-34. PubMed ID: 25727442
[TBL] [Abstract][Full Text] [Related]
19. Nicotine patch vs. nicotine lozenge for smoking cessation: an effectiveness trial coordinated by the Community Clinical Oncology Program.
Schnoll RA; Martinez E; Tatum KL; Glass M; Bernath A; Ferris D; Reynolds P
Drug Alcohol Depend; 2010 Mar; 107(2-3):237-43. PubMed ID: 20004065
[TBL] [Abstract][Full Text] [Related]
20. A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of a Nicotine Mint Lozenge (2 and 4 mg) in Smoking Cessation.
Xiao D; Kotler M; Kang J; Wang C
J Addict Med; 2020; 14(1):69-77. PubMed ID: 31658113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
